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Michael J. McPherson*[a]
For some homodimeric copper amine oxidases (CuAO), there is
suggestive evidence of differential activity at the two active
sites implying potential cooperativity between the two mono-
mers. To examine this phenomenon for the Arthrobacter globi-
formis CuAO (AGAO), we purified a heterodimeric form of the
enzyme for comparison with the homodimer. The heterodimer
comprises an active wild-type monomer and an inactive mono-
mer in which an active-site tyrosine is mutated to phenyl-
alanine (Y382F). This mutation prevents the formation of the
trihydroxyphenylalanine quinone (TPQ) cofactor. A pETDuet
vector and a dual fusion tag strategy was used to purify heter-
odimers (WT/Y382F) from homodimers. Purity was confirmed
by western blot and native PAGE analyses. Spectral and kinetic
studies support the view that whether there are one or two
functional monomers in the dimer, the properties of each func-
tional monomer are the same, thus indicating no communica-
tion between the active sites in this bacterial enzyme.
Copper amine oxidases (CuAOs) [E.C. 1.4.3.6] have been stud-
ied since 1929.[1] They are homodimers with subunit sizes rang-
ing from 70 to 120 kDa.[2] Each subunit contains a single post-
translationally derived protein cofactor, 2,4,5-trihydroxyphenyl-
alanine quinone (TPQ), and a mononuclear type II cupric ion
centre. The biogenesis of TPQ in CuAOs is catalysed by a
single turn-over reaction from an active-site tyrosine residue in
the presence of CuII and molecular oxygen.[3] CuAOs catalyse
the oxidative deamination of primary amines to their corre-
sponding aldehydes with a concomitant release of NH3 and
H2O2 through reductive and oxidative half reactions.
Previous studies have demonstrated that CuAOs are only
functional in their dimeric form; this suggests that dimerisation
affords structural and/or functional integrity.[4] Further studies
have provided evidence for communication between the subu-
nits in the dimer in some CuAOs, though this evidence cannot
be regarded as definitive.[5] The initial evidence came from the
results of titration of the TPQ cofactor with hydrazine-based
mechanistic inhibitors.[5a] These studies demonstrated that, in
some CuAOs, such as pea seedling amine oxidase (PSAO) and
lentil seedling amine oxidase (LSAO), two TPQs were readily ti-
tratable; this is consistent with no communication between
the two active sites.[5b,6] There are conflicting reports regarding
differential reactivity between the two TPQs in bovine serum
amine oxidase (BSAO).[5c–e] Morpurgo and colleagues report dif-
ferential reactivity of the two TPQ’s in the BSAO dimer.[5d,e] By
contrast, for highly purified BSAO, Janes and Klinman demon-
strated titration of up to 0.9 TPQ/subunit with corresponding
enzyme activity, thereby indicating that each subunit contains
active TPQ although, as the authors state, this does not neces-
sarily mean that under steady-state conditions each subunit is
catalytically competent.[5c] Choi et al. reported a titration of
0.62 TPQ/subunit with phenylhydrazine for Arthrobacter globi-
formis amine oxidase (AGAO). However, they were unable to
say whether less than one TPQ per subunit is formed or if
there is reduced reactivity of one of the TPQ’s in the dimer as
a consequence of modification of the other TPQ by the inhibi-
tor.[5f]
In other amine oxidases such as pig plasma amine oxidase
(PPAO)[5a] and Aspergillus nidulans amine oxidase (ANAO),[4] dif-
ferential reactivity between the two TPQs has been reported,
thus suggesting the possibility of communication between the
active sites. In support of these observations, structural studies
of Escherichia coli amine oxidase (ECAO) in complex with 2-hy-
drazinopyridine (2-HP), revealed that one of the TPQ sites re-
acted much more quickly than the second site, which required
prolonged exposure to 2-HP to react.[7] These structural data
correlated with solution studies that demonstrated that 1.5
TPQs could be titrated with molar equivalent amounts of 2-HP.
However, two TPQs per dimer could be titrated following incu-
bation with a 20-fold molar excess of inhibitor.[7a] This implied
that a population of TPQ was initially inaccessible and raised
the possibility of negative cooperativity between the two
active sites. The most obvious, and significant, interaction be-
tween the monomers in the CuAO dimer occurs through two
long b-hairpin structures: arm I and arm II. Arm I consists of
residues conserved across the CuAO enzyme family and it
extends from one monomer to form a network of hydrogen
bonds in close proximity to the active site of the other mono-
mer (Figure 1).[2f] Mutagenesis studies on A. globiformis hista-
mine oxidase showed that altering a conserved aspartate to
glutamine—D403Q (=D383 in AGAO)—increased the turnover
rate of the enzyme.[8] Furthermore, characterisation of a similar
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residue in Hansenula polymorpha amine oxidase-1 (HPAO-1)—
E406 (=D383 in AGAO, Figure 1)—revealed that the hydrogen-
bond network has a role in both TPQ biogenesis and cataly-
sis.[9] There is no evidence at this time for a role for these inter-
actions in cooperativity between subunits in AGAO.
Mutating the residues associated with the inter-subunit in-
teractions within one monomer of the dimer might afford a
better understanding of the relationship between dimerisation
and enzyme activity in CuAO through studying heterodimeric
forms of the enzyme. The most common method used to form
heterodimers of enzymes with differentially mutated subunits
involves dissociating two forms of homodimer, followed by
random re-association of monomers giving rise to three dimer
combinations: the two original homodimers plus heterodim-
ers.[10] However, reported heterodimer yields have been low.
Recent studies have demonstrated more efficient methods for
obtaining higher yields of the desired heterodimer.[10] Ohgari
et al. coexpressed wild-type and mutant proteins by using the
pETDuet system to give 25% wild-type dimer, 50% heterodi-
mer and 25% mutant dimer yield. Castellani et al. used a dual-
affinity-tag system to isolate heterodimer; this ensured low
cross contamination of the heterodimer with either homodi-
mer.[11]
In order to study the reported cooperativity in CuAOs more
rigorously, we combined these methods. Initially we tested the
E. coli enzyme, but this proved technically challenging, so we
developed a coexpression and purification system for heterodi-
meric forms of AGAO as a model system for this proof-of-prin-
ciple study. We demonstrate here the use of a coexpression
vector, pETDuet-1, to isolate heterodimers comprising differen-
tially tagged wild-type monomer and inactive Y382F monomer,
in which the TPQ precursor Tyr382 is mutated to phenylala-
nine, are combined (Scheme 1).
Methods described by Ohgari et al. and Juda et al. were
adapted for the construction and expression of AGAO hetero-
dimers.[11b,12] Briefly, a C-terminal Strep-tag II version of the
wild-type agao coding region (provided by Prof. David Dooley,
University of Rhode Island) and a C-terminal His6-tagged agao
Y382F coding region were subcloned into multiple cloning re-
gions 1 and 2, respectively, to give plasmid pETDuet-agaoWT/
Y382F. Expression of protein from pETDuet-agaoWT/Y382F re-
sults in three potential dimer species (Scheme 1).
To isolate heterodimeric WT/Y382F, a two-step affinity purifi-
cation procedure was employed: an initial Cu2+-immobilised
affinity chromatography step to remove WT dimers and then
a StrepTactin affinity chromatography step to remove Y382F
homodimers. Wild-type AGAO (WT/WT) and the inactive
mutant (Y382F/Y382F) were purified separately as experimental
controls. The purification of heterodimeric or homodimeric
populations together with experimentally mixed homodimers
allowed for direct and rapid confirmation by western blot anal-
ysis of the subunit composition. Immunoblotting with an anti-
Strep tag II antibody detected both WT/WT and WT/Y382F
AGAO dimers, whereas Y382F/Y382F and WT/Y382F AGAO
dimers were detected by an anti-polyhistidine antibody. Immu-
noblotting for each tag (Strep tag II and His6 tag) independent-
ly confirmed the presence and purity of heterodimeric WT/
Y382F AGAO (Figure 2).
Figure 1. b-Hairpins (arm I) linking the active sites of AGAO monomers
through a conserved hydrogen bond. b-Strands are drawn as flat arrows col-
oured light grey for monomer A and dark grey for monomer B. Some key
residues in the active site are drawn as sticks coloured by chain. Apart from
D383, the residues (T378, D357 and H355) are not referred to in the text. Hy-
drogen bonds are represented by dashed black lines.
Scheme 1. Production of AGAO heterodimers. A) C-terminal Strep-tagged
WT and C-terminal His6-tagged Y382F genes were cloned into pET-Duet-1.
B) Protein expression from pETDuet-agao WT/Y382F produced three dimeric
forms of the enzyme.
Figure 2. SDS-PAGE (Coomassie Brilliant Blue-stained gels) and western blot
analysis of the subunit combinations: &: WT, *: Y382F.
ChemBioChem 2015, 16, 559 – 564 www.chembiochem.org Ó 2015 The Authors. Published by Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim560
Communications
Theoretical calculations of isoelectric point (pI, ExPASy;
http://web.expasy.org/compute_pi/) indicated that each dimer
would have a different pI indicative of changes to the overall
charge due to the fusion tags (WT/WT pI=5.07, WT/Y382F pI=
5.15 and Y382F/Y382F pI=5.23).[13] Furthermore, under alkaline
conditions the Strep tag II (WSHPQEK) is protonated whilst the
His6 tag (HHHHHH) is deprotonated. Subsequent analysis by
native PAGE at pH 8.8 demonstrated differential migration pat-
terns for these three protein dimers, thereby confirming the
predicted differences in overall protein charge and migration
characteristics of the three AGAO dimers and confirming puri-
fication of the heterodimer (Figure 3). Following prolonged
incubation of heterodimer protein samples with subsequent
native PAGE established that there was no random dissociation
and reassociation of the dimers as only a single band was ob-
served for WT/Y382F AGAO with no evidence of the appear-
ance of homodimers. As the native PAGE and immunoblot
data demonstrated successful isolation of the heterodimeric
WT/Y382F, spectral and steady-state kinetic studies were un-
dertaken. The presence of protein-derived cofactor, TPQ, pro-
vides a clear spectral signature with lmax=480 nm.
[3b] UV–visi-
ble spectra of purified WT/WT, WT/Y382F and Y382F/Y382F
AGAO dimers revealed an absorption peak at 480 nm for WT/
WT and WT/Y382F samples but not for the Y382F/Y382F AGAO
variant, which cannot form TPQ. The molar extinction coeffi-
cient for WT/Y382F (1752m¢1cm¢1) is half that of WT/WT
(3437m¢1cm¢1) ; this indicates a 50% lower TPQ content. The
absence of shifts in lmax in WT/Y382F compared with WT/WT
indicates that there is no apparent change in the electronic
structure of the TPQ in the heterodimer (Figure 4A).
To support the UV–visible data, the WT/WT, WT/Y382F and
Y382/Y382F dimers were incubated with a 20-fold molar
excess of 2-HP to react with the TPQ in each protein. 2-HP is a
mechanism-based inhibitor of CuAOs (Scheme 2)[5a] that gives
the yellow coloured complex, adduct I.[14] A change in solution
colour from pink (unreacted TPQ at 480 nm) to yellow (ad-
duct I complex at 420 nm) was only observed with WT/WT and
WT/Y382F AGAOs, but not with Y382F/Y382F, as expected (Fig-
ure 4B).
Spectrophotometric quantification of adduct I in equal quan-
tities of protein revealed that heterodimeric WT/Y382F AGAO
(0.072 a.u) formed only half the quantity of adduct I than the
WT/WT AGAO (0.145 a.u) homodimer did. Post-translational
modification of Y382 to TPQ in the WT subunit of the WT/
Y382F AGAO heterodimer indicates that the Y382F mutation of
in one monomer has no effect upon TPQ formation in the
other.
To quantify the content of TPQ in active WT/WT, inactive
Y382F/Y382F and heterodimeric WT/Y382F AGAOs, the en-
zymes were titrated with 2-HP. This indicated 1.5 TPQs per
dimer of the WT/WT enzyme and is consistent with the 1.4
TPQs per dimer reported previously.[12] Many questions have
been raised about the failure to detected one TPQ per mono-
mer in many CuAOs.
Does this population exist as TPQ or an unreactive precur-
sor? Does the conformation of the active site prevent a popula-
tion reacting or does inter-subunit communication lead to a
conformation change in the neighbouring active site? In heter-
odimeric WT/Y382F AGAO, 0.8 TPQs were titrated per dimer
and, as expected from the results with excess 2-HP, no TPQ
was detected upon titration of the inactive homodimer Y382F/
Figure 3. Native PAGE gel displaying the difference in migration of WT/WT
(&&) AGAO, WT/Y382F (&*) AGAO and Y382F/Y382F (**) AGAO.
Figure 4. A) UV/Vis spectra of WT/WT (c), WT/Y382F (–––) and Y382F/
Y382F AGAO (····; all 64 mm) in HEPES buffer (50 mm, pH 7.0). B) Adduct I UV/
Vis spectra of WT/WT, WT/Y382F and Y382F/Y382F AGAO (all 26 mm) supple-
mented with 2-HP (0.52 mm) in potassium phosphate (100 mm, pH 7.0).
Scheme 2. The irreversible reaction of TPQ with 2-HP.
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Y382F (Figure 5). The data show that heterodimeric WT/Y382F
has approximately half the quantity of reactive TPQs of the
WT/WT AGAO. Ruggiero and Dooley observed 70–80% efficien-
cy in TPQ biogenesis in AGAO, as the amount of oxygen con-
sumed correlated to the amount of TPQ formed, typically
0.65–0.85 mol of TPQ per mol of subunit.[15] Taking this into
account, it seems most likely that about 20% of the precursor
tyrosine fails to undergo full processing to form the cofactor
TPQ, resulting in the detection of less than one TPQ in the
heterodimer WT/Y382F.
The catalytic activity of AGAO was assessed in a peroxidase-
coupled assay, as described in Chiu et al. ,[16] with b-phenyl-
ethylamine (b-PEA) as the substrate. The KM values for b-PEA of
WT/WT and WT/Y382F AGAOs are similar (1.30.1 vs. 1.6
0.2 mm, respectively). Oxidation of b-PEA also displays substrate
inhibition in 100 mm HEPES (pH 7.0),[17] and therefore a similar
trend was observed upon comparison of the Ki values of the
WT/WT and WT/Y382F AGAOs (198.235.7 vs. 208.226.9 mm,
respectively; Table 1).[17] This suggests that inactivating one
monomer has no effect on either substrate binding or sub-
strate inhibition in the active monomer. The turnover rate (kcat)
of WT/Y382F AGAO per dimer is 65.51.9 s¢1, which is approx-
imately half that of WT/WT AGAO (129.55.1 s¢1). Although
heterodimeric WT/Y382F AGAO exhibits half the total catalytic
efficiency of the WT/WT AGAO homodimer, due to one inactive
subunit (4Õ107 vs. 9.96Õ107m¢1 s¢1, respectively), the catalytic
efficiencies per wild-type monomer in heterodimer or homo-
dimer AGAO are similar (Table 1).
The steady-state kinetic data are in agreement with the TPQ
titration data thus indicating that inactivating one active site in
AGAO has no effect on the reactivity of a second functional
active site. The TPQ titration data imply that inefficiency in
TPQ biogenesis results in the formation of less than two TPQs
in AGAO. However, we cannot exclude the possibility that
a population of TPQ is inaccessible to 2-HP. That inactivating
one subunit has no significant effect on the activity of the
active subunit suggests that, in AGAO, the subunits act inde-
pendently of each other. This suggests that replacing the TPQ
in one subunit with phenylalanine does not appear to change
the hydrogen-bond network involved in interactions with the
b-hairpin, and, consequently, the activity in the other subunit
is unaffected. The independent catalytic activity of each sub-
unit suggests that dimerisation is likely to confer structural
stability on AGAO. However, continued study of other hetero-
dimers variants will allow for more detailed investigations into
the function of dimerisation in AGAO and in other CuAOs.
In conclusion, we report purification of the first heterodimer-
ic form of a CuAO. The data suggest that the subunits are cata-
lytically independent in AGAO, thus there is no subunit coop-
erativity. Heterodimeric forms of CuAOs will allow the study of
differentially mutated subunit combinations within the dimer
and will further facilitate the dissection of structural features
associated with enzyme function.
Experimental Section
Cloning: The C-terminal Strep-tagged wild-type AGAO gene was
PCR amplified from pAGO2 and subcloned into pET28c. Prior to
constructing pET28c_Y382F, the pET28c_WTAGAO construct was
altered to remove an internal NcoI site by a single base mutation
at base pair 1377 (C!G); this maintained the same codon using
the following primers: reverse primer: 5’-GTGGT CCGGC AAACG
ATGGG CCCGG GC-3’, Forward primer: 5’-GCCCG GGCCC ATCGT
TTGCC GGACC AC-3’. pET28c_Y382F was constructed by using site-
directed mutagenesis with the following primers in which the
mutated nucleotide is shown in bold, underlined; forward primer:
5’-CACCA CTATC GGCAA CTTCG ACTAC GGCTT CTACT GG-3’ and
reverse primer: 5’-GTGGT GATAG CCGTT GAAGC TGATG CCGAA
GATGA CC-3’.
The Y382F and WT AGAO coding genes were subcloned into the
coexpression vector, pETDuet-1. The Strep-tagged WTAGAO coding
region was amplified by PCR with the following primers: 5’-CATGC
CATGG GCACG CCCTC CACTA TCCAA ACAGC-3’ and 5’-CCCAA
GCTTG GGTCA TTTCT CAAAC TGCGG-3’ which introduced unique
restriction sites, NcoI and HindIII (bold, underlined) respectively.
The amplified fragment was subcloned into multiple cloning site-
1 (MCS1) of pETDuet-1.
The same procedure was used for the Y382F gene. The Y382F
coding gene was amplified by PCR using the following primers:
forward primer: 5’-GGAAT TCCAT ATGAC GCCCT CCACT ATCCA
AACAG C-3’ and reverse primer: 5’-CCGCT CGAGC GGTCA GTGAT
Figure 5. TPQ titrations of WT/WT (&), WT/Y382F (*) and Y382F/Y382F (~)
AGAO with 2-hydrazinopyridine. The absorbance decrease observed at high
molar ratios of 2-HP to AGAO is due to the slow conversion of the hydra-
zone form of adduct I to adduct II. Spectra are the average of three meas-
urements, and absorbance values were corrected for progressive dilution
caused by addition of 2-HP.
Table 1. Kinetic parameters of AGAO dimers for b-phenylethylamine.[a]
Dimer KM [mm] kcat [s
¢1] Ki [mm] kcat/KM [m
¢1 s¢1]
(dimer)
WT/WT 1.3 (0.1) 129.5 (5.1) 198.2 (35.7) 9.96Õ107
(8.6Õ106)
WT/Y382F 1.6 (0.2) 65.5 (1.9) 208.2 (6.9) 4Õ107
(5.3Õ106)
[a] Assays conducted under air-saturating conditions at 25 8C in HEPES
(50 mm, pH 7.0). No turnover was detected for the inactive Y382F/Y382F
variant.
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GATGA TGATG ATGCC GTGGC AGTGG GAGCC-3’ which introduced
unique restriction sites NdeI And XhoI (bold, underlined), respec-
tively. The reverse primer also introduced a His-tag site that re-
placed the Strep-tag site. The fragment was subcloned into multi-
ple cloning site-2 (MSC2) of coexpression vector pETDuet-1. The
Strep-tagged WT AGAO and His6-tagged Y382F coding regions
were subcloned both separately and together into pETDuet-1 to
form pETDuet-WT, pETDuet-Y382F and pETDuet-WT/Y382F. Each
construct was confirmed by diagnostic restriction enzyme digests
followed by DNA sequencing.
Protein expression and purification: The AGAO enzymes were ex-
pressed as described in Juda et al.[12] All the purification steps were
carried out at 4 8C. Post-lysis, CuSO4 (50 mm) was added to the ly-
sates, and they were incubated at 30 8C for 1 h with shaking at
100 rpm. This step was performed to ensure the full processing of
tyrosine to TPQ. Excess CuSO4 was removed by dialysing the lysate
against binding buffer phosphate-buffered saline (PBS, 140 mm
NaCl, 2.68 mm KCl, 10 mm Na2-HPO4, 2 mm KH2PO4, pH 7.4) or
sodium phosphate (20 mm containing 300 mm NaCl, pH 7.4). Wild-
type AGAO (WT/WT) was purified by using Strep-Tactin chromatog-
raphy.[12] The column was prepared according to the manufactur-
er’s protocol (Strep-Tactin Sepharose 50% suspension, IBA, Gçttin-
gen, Germany). The lysate was syringe filtered prior to loading the
Strep-Tactin column. The protein-bound column was washed with
binding buffer to remove unbound and non-specific binding pro-
teins. The enzyme was eluted with PBS supplemented with [D]des-
thiobiotin (5 mm). Homogeneous fractions were pooled and dia-
lysed against HEPES (50 mm, pH 7).
The inactive mutant (Y382F/Y382F) was purified by using Cu2+-im-
mobilised metal affinity chromatography. The dialysed lysate was
filtered through a 0.2 mm syringe filter to remove any remaining
cell debris. Prior to sample loading, the column was charged with
NiSO4 (0.1m) and equilibrated with sodium phosphate (20 mm con-
taining 300 mm NaCl, pH 7.4). After the sample had been loaded,
the column was washed with sodium phosphate (20 mm contain-
ing 300 mm NaCl, 40 mm imidazole, pH 7.4). Bound protein was
eluted with sodium phosphate (20 mm containing 300 mm NaCl,
250 mm imidazole, pH 7.4).Homogenous fractions were then
pooled and dialysed against HEPES (50 mm, pH 7).
The heterodimer (WT/Y382F) was isolated according to a two-step
affinity purification procedure that involved both Cu2+-immobilised
affinity chromatography and Strep-Tactin affinity chromatography.
The column was charged with CuSO4 (0.1m), washed to remove
unbound Cu2+ and equilibrated with sodium phosphate (20 mm),
NaCl (300 mm) pH 7.4. The protein-bound column was washed
with sodium phosphate (20 mm containing 500 mm NaCl, 40 mm
imidazole, pH 7.4). Elution was carried out using sodium phosphate
(20 mm containing 500 mm NaCl, 50 mm EDTA, pH 7.4). One frac-
tion was collected, analysed by SDS-PAGE and dialysed against PBS
in preparation for Strep-Tactin chromatography. The purification
procedure was similar to that used for WT/WT. The purity and ho-
mogeneity of the eluted protein was assessed by SDS-PAGE, and
the protein was dialysed overnight against HEPES (50 mm, pH 7).
Western blot: After being separated on a SDS-PAGE (15%) gel, the
proteins were transferred to two identical polyvinylidene fluoride
(PVDF) membranes (Immobilon, Millipore) by using an XCell II
module apparatus (Invitrogen). Following transfer, the membranes
were blocked in dried skimmed milk (Marvel, 5%, w/v) in Tris-buf-
fered saline (150 mm NaCl, 50 mm Tris·HCl, pH 7.5) containing
Tween-20 (TBS-T, 0.1%) and bovine serum albumin (BSA, 5%, w/v)
in TBS-T for 1 h. One membrane was then incubated overnight at
4 8C in TBS-T with dried skimmed milk (5%, w/v) and supplemented
with the monoclonal anti-polyhistidine peroxidise conjugate anti-
body (Sigma); the other membrane was incubated in BSA (5%,
w/v) and TBS-T containing the primary anti-Strep tag II antibody
(Novagen). After incubation, the unbound antibody was washed
off in TBS-T. The second membrane was then incubated for 1 h in
BSA (5%, w/v) and TBS-T supplemented with a horseradish per-
oxidase-conjugated secondary antibody (Sigma) for 1 h. The un-
bound secondary antibody was washed off with TBS-T. The pro-
teins were detected by using chemiluminescence.
Native PAGE: The traditional Tris–glycine system was used; the
proteins were separated by using a native polyacrylamide gel
(12%). Electrophoresis was carried out at 4 8C and 200 V for 1–2 h,
and the proteins were detected by staining with Coomassie Bril-
liant Blue R.
Kinetic assays: AGAO activity was assessed by use of the perox-
idase-coupled assay described by Chiu et al.[16] Briefly, enzyme ac-
tivity was assayed at 30 8C in HEPES buffer (100 mm, pH 7) with
various concentrations of b-phenylethylamine (0.5–160 mm). The
reactions were followed by monitoring H2O2 production, which
oxidises 2,2’-azinobis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS;
2 mm ; e414=24600m
¢1cm¢1) using horseradish peroxidase (HRP;
10 unitsmL¢1). The data were fitted to Equation 1 by using Origin
Pro 7.5 (Microcal, MA, USA) [Eq. (1)] .[17]
V ¼ Vmax½S¤
Km þ ½S¤ þ ½S2¤=K i ð1Þ
UV–visible spectroscopic studies and TPQ titrations: UV–visible
spectra were obtained on a Shimadzu UV2401 PC spectrophotom-
eter equipped with a temperature-controlled cell holder. The pro-
teins were treated with a 20-fold molar excess of 2-HP in HEPES
(100 mm, pH 7). Spectral changes associated with this addition of
2-HP to WT/WT, Y382F/Y382F and WT/Y382F AGAO were moni-
tored over time, typically 5–10 min, until there were no further
changes. TPQ titrations were carried out as previously described.
2-HP was prepared at a molar concentration ten times that of the
dimer. TPQ was titrated stepwise by adding 2-HP (0.1 equiv).
Changes in absorbance were accounted for by correcting for the
dilution (1%) at each addition of 2-HP. Following addition of 2-HP,
the reactions were allowed to proceed until no detectable change
in absorbance was observed.
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